Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.36 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30559586 | 1.00 | MME (0.36) | MMECPB2 | |
| SCHEMBL2132230 | 1.00 | MME (0.36) | MMECPB2 | |
| SCHEMBL30272502 | 0.97 | MME (0.34) | MMECPB2 | |
| SCHEMBL29630312 | 0.97 | MME (0.34) | MMECPB2 | |
| SCHEMBL29630315 | 0.95 | MME (0.36) | MME | |
| SCHEMBL29590288 | 0.95 | MME (0.36) | MME | |
| SCHEMBL29777856 | 0.94 | MME (0.39) | MMECPB2 | |
| SCHEMBL29461527 | 0.93 | MME (0.39) | MME | |
| SCHEMBL30781267 | 0.93 | BACE1 (0.34) | — | |
| SCHEMBL29374958 | 0.93 | MME (0.36) | MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-60248618-A | — | — | None | — | — | JP | disclosed |
| EP-3971169-B1 | METHOD FOR PRODUCING, IN A CELL, A PROTEIN OR A POLYPEPTIDE COMPRISING A TETRAZINE AMINO ACID | UNIV OREGON STATE (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-4703370-A1 | AMINO ACID-DERIVED CERAMIDE, SYNTHESIS METHOD THEREFOR AND USE THEREOF | Shenzhen Dikeman Biotechnology Co., Ltd. (CN) | 2026-03-04 | — | — | EP | disclosed |
| US-12552854-B2 | Peptides that block presentation of antigenic islet peptides by HLA-DQ8 and methods for treating type-1 diabetes | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2026-02-17 | — | — | US | disclosed |
| US-20260028320-A1 | REAGENTS AND METHODS FOR BIOORTHOGONAL LABELING OF BIOMOLECULES IN LIVING CELLS | OREGON STATE UNIVERSITY (US) | 2026-01-29 | — | — | US | disclosed |
| US-20260009071-A1 | METHODS OF IN-SOLUTION POSITIONAL CO-BARCODING FOR SEQUENCING LONG DNA MOLECULES | MGI TECH CO LTD (CN) | 2026-01-08 | — | — | US | disclosed |
| CN-121045324-A | L-seryl-L-histidine crystal form compound and preparation method thereof | 深圳瑞德林生物技术有限公司 | 2025-12-02 | — | — | CN | disclosed |
| CN-121045324-A | L-seryl-L-histidine crystal form compound and preparation method thereof | 深圳瑞德林生物技术有限公司 | 2025-12-02 | — | — | CN | disclosed |
| EP-4637797-A1 | METHOD FOR OBTAINING AN EXTRACT OF PLANT ORIGIN, A COMPOSITION CONTAINING IT AND ITS COSMETIC USE | SEDERMA (FR) | 2025-10-29 | — | — | EP | disclosed |
| EP-4562143-A1 | METHODS OF IN-SOLUTION POSITIONAL CO-BARCODING FOR SEQUENCING LONG DNA MOLECULES | MGI Tech Co., Ltd. (CN) | 2025-06-04 | — | — | EP | disclosed |
| US-20140227345-A1 | COMPONENTS FOR PRODUCING AMPHOTERIC LIPOSOMES | MARINA BIOTECH, INC. (US) | 2014-08-14 | — | — | US | disclosed |
| US-8580297-B2 | Components for producing amphoteric liposomes | MARINA BIOTECH, INC. (US) | 2013-11-12 | — | — | US | disclosed |
| US-20120100205-A1 | COMPONENTS FOR PRODUCING AMPHOTERIC LIPOSOMES | MARINA BIOTECH, INC. | 2012-04-26 | — | — | US | disclosed |
| WO-2011086553-A1 | CYCLIC PEPTIDES, COMPOSITIONS COMPRISING THEM AND USES THEREOF AS NUCLEASES OF NUCLEOTIDIC MACROMOLECULES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. (IL) | 2011-07-21 | — | — | WO | disclosed |
| US-20090047272-A1 | Compositions with Modified Nucleases Targeted to Viral Nucleic Acids and Methods of Use for Prevention and Treatment of Viral Diseases | NANONASE, INC. | 2009-02-19 | — | — | US | disclosed |
| EP-1734991-A2 | COMPOSITIONS WITH MODIFIED NUCLEASES TARGETED TO VIRAL NUCLEIC ACIDS AND METHODS OF USE FOR PREVENTION AND TREATMENT OF VIRAL DISEASES | Avirid, Inc. (US) | 2006-12-27 | — | — | EP | disclosed |
| WO-2005115444-A2 | COMPOSITIONS WITH MODIFIED NUCLEASES TARGETED TO VIRAL NUCLEIC ACIDS AND METHODS OF USE FOR PREVENTION AND TREATMENT OF VIRAL DISEASES | AVIRID, INC. (US) | 2005-12-08 | — | — | WO | disclosed |
| US-20050164963-A1 | Components for producing amphoteric liposomes | CAVALRY FUND I LP | 2005-07-28 | — | — | US | disclosed |
| WO-2002040631-A2 | DIPEPTIDE SERYL-HISTIDINE AND RELATED OLIGOPEPTIDES CLEAVE DNA, PROTEIN, AND A CARBOXYL ESTER | OHIO UNIVERSITY (US) | 2002-05-23 | — | — | WO | disclosed |
| JP-S60248618-A | DIPEPTIDE-CONTAINING REMEDY FOR ULCER | NIPPON ZOKI PHARMACEUT CO LTD | 1985-12-09 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260009071-A1 | METHODS OF IN-SOLUTION POSITIONAL CO-BARCODING FOR SEQUENCING LONG DNA MOLECULES | RNGTT, POLM, NUDT21 | MME 2812/4885CPB2 2727/4885 |
| US-20140227345-A1 | COMPONENTS FOR PRODUCING AMPHOTERIC LIPOSOMES | PHOSPHO1, SGMS1, CHMP4B | MME 1442/4885CPB2 2298/4885 |
| US-12552854-B2 | Peptides that block presentation of antigenic islet peptides by HLA-DQ8 and methods for treating type-1 diabetes | IAPP, HLA-DRB1, MICA | MME 777/4885CPB2 1434/4885 |
| US-20050164963-A1 | Components for producing amphoteric liposomes | PHOSPHO1, SGMS1, CHMP4B | MME 1442/4885CPB2 2298/4885 |
| US-20260028320-A1 | REAGENTS AND METHODS FOR BIOORTHOGONAL LABELING OF BIOMOLECULES IN LIVING CELLS | TET1, TET3, PTMS | MME 3207/4885CPB2 1015/4885 |
| US-20120100205-A1 | COMPONENTS FOR PRODUCING AMPHOTERIC LIPOSOMES | PHOSPHO1, SGMS1, CHMP4B | MME 1442/4885CPB2 2298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.